BELMONT, Calif., March 16, 2011 /PRNewswire/ -- Phalanx Biotech Group, a global provider of genomic analysis services, announces its newest expression microarray the Rat Whole Genome OneArray®. Curated from RefSeq.42 and Ensemble.59 databases, the Rat OneArray® is comprised of 25,338 long-oligonucleotide probes engineered to meet specific isothermal requirements for superb hybridization performance. This microarray features data reproducibility with CV<4% and demonstrates high correlation with qPCR. The Rat OneArray® provides the most current coverage against the latest rat gene annotations as compared to other commercially available arrays - offering excellent interrogation power into pathways observed in rat disease models and ADMET/DMPK studies.
"Amidst an environment of budget constraints, the release of our high-quality and affordable rat microarray is timely for the rat model research community particularly with increased efforts toward understanding the underlying mechanisms of neurological and inflammatory diseases," said Lester Lien, President, US Operations. "Furthermore, as the FDA starts requiring toxicogenomic data in new drug applications, expression profiling in rat models will be necessary for biomarker development and validation in the drug development process."
The OneArray® product line consists of microarrays for whole genome gene expression available in Human, Mouse, Rat and Yeast, as well as microRNA profiling in all miRBase species. Each array conforms to the strictest quality control standards and is manufactured using proprietary PhalanxJet spotting technology, specialized coating chemistry, and a fully automated assembly system. Phalanx Biotech's unparalleled expertise in microarray technologies forms the basis for an exceptional OneArray® Service Team dedicated to offering genomic research solutions from sample preparation to data interpretation. Leveraging a high-throughput manufacturing facility and streamlined service center, Phalanx offers a continuum of affordable products and services addressing the profiling needs of scientists in areas ranging from discovery research to toxicogenomic testing.
About Phalanx Biotech Group
Phalanx Biotech Group, with operations in California and Taiwan, provides genomics research products and services worldwide to academic, pharmaceutical and biotech communities. Built on world-class, integrated-chip foundry technology, Phalanx Biotech has developed the OneArray® line of high-quality and affordable microarrays for expression profiling of whole genomes, miRNA, and custom targets. Our highly-trained service specialists provide a comprehensive offering of gene expression and miRNA profiling services for biomarker discovery including sample preparation, expression analysis, and qPCR validation. For more information about our products and services, please visit our website at www.phalanxbiotech.com
CONTACT: Audrey Fisher, +1-650-320-8669, email@example.com
SOURCE Phalanx Biotech Group